9th Circ. Rules Endologix Stock Suit 'Had No Basis In Logic'
The Ninth Circuit said in a published opinion Wednesday that a proposed class action accusing Endologix Inc. of misleading investors about regulatory approval for a new medical product "had no basis...To view the full article, register now.
Already a subscriber? Click here to view full article